HIF1A and B-cell chronic lymphocytic leukemia: Primary CLL cells treated with PCI-24781 or LY294002 also resulted in decreased pAKT (Thr 308) and HIF-1α, which was further decreased with the combination of the two drugs (Figure 5C).